CA1326440C - Milieu de conservation synthetique de globules rouges et de plaquettes exempt de plasma - Google Patents

Milieu de conservation synthetique de globules rouges et de plaquettes exempt de plasma

Info

Publication number: CA1326440C
Authority: CA; Canada
Prior art keywords: grams; gram; red blood; storage medium; blood cell
Prior art date: 1987-09-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA000577883A

Other languages

English (en)

Inventor

Stein Holme

William Andrew Lambert Heaton

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

American National Red Cross

Original Assignee

American National Red Cross

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-09-21

Filing date

1988-09-20

Publication date

1994-01-25

1988-09-20 Application filed by American National Red Cross filed Critical American National Red Cross

1994-01-25 Application granted granted Critical

1994-01-25 Publication of CA1326440C publication Critical patent/CA1326440C/fr

2011-01-25 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

210000003743 erythrocyte Anatomy 0.000 title claims abstract description 101
210000001772 blood platelet Anatomy 0.000 title claims abstract description 16
210000004027 cell Anatomy 0.000 claims abstract description 22
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 21
239000008121 dextrose Substances 0.000 claims abstract description 21
239000008151 electrolyte solution Substances 0.000 claims abstract description 17
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims abstract 24
235000017557 sodium bicarbonate Nutrition 0.000 claims abstract 12
229910000030 sodium bicarbonate Inorganic materials 0.000 claims abstract 12
239000001509 sodium citrate Substances 0.000 claims abstract 12
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims abstract 12
210000004369 blood Anatomy 0.000 claims description 110
239000008280 blood Substances 0.000 claims description 110
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 31
239000003792 electrolyte Substances 0.000 claims description 8
238000000034 method Methods 0.000 claims description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
239000012141 concentrate Substances 0.000 claims description 4
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims 16
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims 16
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 16
229930024421 Adenine Natural products 0.000 claims 8
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims 8
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims 8
229960000643 adenine Drugs 0.000 claims 8
239000001110 calcium chloride Substances 0.000 claims 8
229910001628 calcium chloride Inorganic materials 0.000 claims 8
229910052943 magnesium sulfate Inorganic materials 0.000 claims 8
235000019341 magnesium sulphate Nutrition 0.000 claims 8
229940045641 monobasic sodium phosphate Drugs 0.000 claims 8
229910000403 monosodium phosphate Inorganic materials 0.000 claims 8
235000019799 monosodium phosphate Nutrition 0.000 claims 8
239000001103 potassium chloride Substances 0.000 claims 8
235000011164 potassium chloride Nutrition 0.000 claims 8
239000011780 sodium chloride Substances 0.000 claims 8
AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims 8
230000000087 stabilizing effect Effects 0.000 claims 4
239000012153 distilled water Substances 0.000 claims 3
239000012503 blood component Substances 0.000 abstract description 4
210000000601 blood cell Anatomy 0.000 description 13
244000201986 Cassia tora Species 0.000 description 10
NCAIGTHBQTXTLR-UHFFFAOYSA-N phentermine hydrochloride Chemical compound [Cl-].CC(C)([NH3+])CC1=CC=CC=C1 NCAIGTHBQTXTLR-UHFFFAOYSA-N 0.000 description 10
150000001875 compounds Chemical class 0.000 description 7
241001163743 Perlodes Species 0.000 description 6
BHMLFPOTZYRDKA-IRXDYDNUSA-N (2s)-2-[(s)-(2-iodophenoxy)-phenylmethyl]morpholine Chemical compound IC1=CC=CC=C1O[C@@H](C=1C=CC=CC=1)[C@H]1OCCNC1 BHMLFPOTZYRDKA-IRXDYDNUSA-N 0.000 description 5
XOHUEYCVLUUEJJ-UHFFFAOYSA-N 2,3-Bisphosphoglyceric acid Chemical compound OP(=O)(O)OC(C(=O)O)COP(O)(O)=O XOHUEYCVLUUEJJ-UHFFFAOYSA-N 0.000 description 4
239000000306 component Substances 0.000 description 4
150000002500 ions Chemical class 0.000 description 4
XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 3
235000015097 nutrients Nutrition 0.000 description 3
230000035939 shock Effects 0.000 description 3
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
241000518994 Conta Species 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
QXAITBQSYVNQDR-UHFFFAOYSA-N amitraz Chemical compound C=1C=C(C)C=C(C)C=1N=CN(C)C=NC1=CC=C(C)C=C1C QXAITBQSYVNQDR-UHFFFAOYSA-N 0.000 description 2
229910052799 carbon Inorganic materials 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
239000013256 coordination polymer Substances 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
238000011084 recovery Methods 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
239000011734 sodium Substances 0.000 description 2
239000000243 solution Substances 0.000 description 2
ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
101710179734 6,7-dimethyl-8-ribityllumazine synthase 2 Proteins 0.000 description 1
101100295756 Acinetobacter baumannii (strain ATCC 19606 / DSM 30007 / JCM 6841 / CCUG 19606 / CIP 70.34 / NBRC 109757 / NCIMB 12457 / NCTC 12156 / 81) omp38 gene Proteins 0.000 description 1
241001279686 Allium moly Species 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
241000861718 Chloris <Aves> Species 0.000 description 1
206010053567 Coagulopathies Diseases 0.000 description 1
239000004803 Di-2ethylhexylphthalate Substances 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
206010018910 Haemolysis Diseases 0.000 description 1
101000973623 Homo sapiens Neuronal growth regulator 1 Proteins 0.000 description 1
241000567769 Isurus oxyrinchus Species 0.000 description 1
101710186609 Lipoyl synthase 2 Proteins 0.000 description 1
101710122908 Lipoyl synthase 2, chloroplastic Proteins 0.000 description 1
101710101072 Lipoyl synthase 2, mitochondrial Proteins 0.000 description 1
101100345589 Mus musculus Mical1 gene Proteins 0.000 description 1
102100022223 Neuronal growth regulator 1 Human genes 0.000 description 1
101150012056 OPRL1 gene Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
241000208474 Protea Species 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
241000120694 Thestor Species 0.000 description 1
240000004543 Vicia ervilia Species 0.000 description 1
239000002253 acid Substances 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
229940037003 alum Drugs 0.000 description 1
239000003146 anticoagulant agent Substances 0.000 description 1
229940127219 anticoagulant drug Drugs 0.000 description 1
101150042295 arfA gene Proteins 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 1
101150071218 cap3 gene Proteins 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
230000035602 clotting Effects 0.000 description 1
239000013065 commercial product Substances 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
101150094817 entB gene Proteins 0.000 description 1
230000008588 hemolysis Effects 0.000 description 1
210000004124 hock Anatomy 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
101150085091 lat-2 gene Proteins 0.000 description 1
239000012528 membrane Substances 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
101150087557 omcB gene Proteins 0.000 description 1
101150115693 ompA gene Proteins 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
239000000843 powder Substances 0.000 description 1
239000000047 product Substances 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
239000002510 pyrogen Substances 0.000 description 1
230000001698 pyrogenic effect Effects 0.000 description 1
230000008961 swelling Effects 0.000 description 1
101150084216 thiB gene Proteins 0.000 description 1
VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
KMIOJWCYOHBUJS-HAKPAVFJSA-N vorolanib Chemical compound C1N(C(=O)N(C)C)CC[C@@H]1NC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C KMIOJWCYOHBUJS-HAKPAVFJSA-N 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/18—Erythrocytes
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2496/00—Reference solutions for assays of biological material
- G01N2496/80—Multi-analyte reference solutions containing cholesterol, glucose and the like
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Immunology (AREA)
Environmental Sciences (AREA)
Urology & Nephrology (AREA)
Molecular Biology (AREA)
Wood Science & Technology (AREA)
Medicinal Chemistry (AREA)
Dentistry (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Developmental Biology & Embryology (AREA)
Virology (AREA)
Analytical Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Physics & Mathematics (AREA)
Food Science & Technology (AREA)
Microbiology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

CA000577883A 1987-09-21 1988-09-20 Milieu de conservation synthetique de globules rouges et de plaquettes exempt de plasma Expired - Fee Related CA1326440C (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US07,099,012		1987-09-21
US07/099,012 US4961928A (en)	1986-03-19	1987-09-21	Synthetic, plasma-free, transfusible storage medium for red blood cells and platelets

Publications (1)

Publication Number	Publication Date
CA1326440C true CA1326440C (fr)	1994-01-25

Family

ID=22272026

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000577883A Expired - Fee Related CA1326440C (fr)	1987-09-21	1988-09-20	Milieu de conservation synthetique de globules rouges et de plaquettes exempt de plasma

Country Status (10)

Country	Link
US (1)	US4961928A (fr)
EP (1)	EP0313808B1 (fr)
AT (1)	ATE97952T1 (fr)
AU (1)	AU619224B2 (fr)
CA (1)	CA1326440C (fr)
DE (1)	DE3886006T2 (fr)
IL (1)	IL87830A0 (fr)
NZ (1)	NZ226280A (fr)
WO (1)	WO1989002274A1 (fr)
ZA (1)	ZA887066B (fr)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5248506A (en) *	1986-03-19	1993-09-28	American National Red Cross	Synthetic, plasma-free, transfusible storage medium for red blood cells and platelets
US5213814A (en) *	1989-04-10	1993-05-25	Cryopharm Corporation	Lyophilized and reconstituted blood platelet compositions
DE3938907C2 (de) *	1989-11-24	1999-11-04	Dade Behring Marburg Gmbh	Mittel zum Lagern und Suspendieren von Zellen, insbesondere Erythrozyten
JP3185108B2 (ja) *	1990-11-07	2001-07-09	バクスター、インターナショナル、インコーポレイテッド	赤血球貯蔵溶液
JPH05503944A (ja) *	1990-11-07	1993-06-24	バクスター、インターナショナル、インコーポレイテッド	血小板貯蔵媒質
US5494590A (en) *	1992-06-11	1996-02-27	Becton Dickinson	Method of using anticoagulant solution in blood separation
JPH09509681A (ja) *	1994-12-16	1997-09-30	バクスター、インターナショナル、インコーポレイテッド	供血者血液特性の制御
US5605934A (en) *	1995-03-23	1997-02-25	Baxter International Inc.	Method of manufacturing and storing solutions
US6527957B1 (en)	1995-08-09	2003-03-04	Baxter International Inc.	Methods for separating, collecting and storing red blood cells
US5783093A (en) *	1997-01-02	1998-07-21	Haemonetics Corporation	Blood cell concentrates using a single solution for anticoagulation and preservation
US5906744A (en) *	1997-04-30	1999-05-25	Becton Dickinson And Company	Tube for preparing a plasma specimen for diagnostic assays and method of making thereof
US5955257A (en) *	1997-10-21	1999-09-21	Regents Of The University Of Minnesota	Infusible grade short-term cell storage medium for mononuclear cells
US7049110B2 (en)	1998-07-21	2006-05-23	Gambro, Inc.	Inactivation of West Nile virus and malaria using photosensitizers
US6258577B1 (en)	1998-07-21	2001-07-10	Gambro, Inc.	Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers
US6277337B1 (en)	1998-07-21	2001-08-21	Gambro, Inc.	Method and apparatus for inactivation of biological contaminants using photosensitizers
US7498156B2 (en)	1998-07-21	2009-03-03	Caridianbct Biotechnologies, Llc	Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US7094378B1 (en)	2000-06-15	2006-08-22	Gambro, Inc.	Method and apparatus for inactivation of biological contaminants using photosensitizers
US7220747B2 (en)	1999-07-20	2007-05-22	Gambro, Inc.	Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US6268120B1 (en)	1999-10-19	2001-07-31	Gambro, Inc.	Isoalloxazine derivatives to neutralize biological contaminants
US7112576B1 (en)	1999-12-10	2006-09-26	Regents Of The University Of Minnesota	Compositions and methods for cryopreservation of peripheral blood lymphocytes
US6492103B1 (en)	2000-01-31	2002-12-10	Organ Recovery Systems, Inc.	System for organ and tissue preservation and hypothermic blood substitution
US7985588B2 (en)	2000-06-02	2011-07-26	Caridianbct Biotechnologies, Llc	Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
TW590780B (en)	2000-06-02	2004-06-11	Gambro Inc	Additive solutions containing riboflavin
US7648699B2 (en)	2000-06-02	2010-01-19	Caridianbct Biotechnologies, Llc	Preventing transfusion related complications in a recipient of a blood transfusion
US9044523B2 (en)	2000-06-15	2015-06-02	Terumo Bct, Inc.	Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US6548241B1 (en) *	2000-11-28	2003-04-15	Gambro, Inc.	Storage solution containing photosensitizer for inactivation of biological contaminants
EP1496947A1 (fr) *	2002-04-24	2005-01-19	Gambro, Inc.	Elimination d'adenine au cours d'un procede de reduction des agents pathogenes du sang ou de composants sanguins
US8828226B2 (en)	2003-03-01	2014-09-09	The Trustees Of Boston University	System for assessing the efficacy of stored red blood cells using microvascular networks
WO2004112477A1 (fr) *	2003-06-20	2004-12-29	Pall Corporation	Traitement de liquides biologiques contenant des plaquettes
US20050186183A1 (en) *	2003-12-08	2005-08-25	Deangelo Joseph	Stabilized products, processes and devices for preparing same
US9314014B2 (en)	2004-02-18	2016-04-19	University Of Maryland, Baltimore	Compositions and methods for the storage of red blood cells
KR100532860B1 (ko) *	2004-07-26	2005-12-02	이미영	환원전리수를 포함하는 단백질 보존액 및 그를 이용한단백질 보존방법
CN101166420B (zh) *	2005-02-17	2015-08-19	辛辛那提大学	贮存红细胞的组合物和方法
US8835104B2 (en)	2007-12-20	2014-09-16	Fenwal, Inc.	Medium and methods for the storage of platelets
US8871434B2 (en) *	2008-03-21	2014-10-28	Fenwal, Inc.	Red blood cell storage medium for extended storage
US8968992B2 (en) *	2008-03-21	2015-03-03	Fenwal, Inc.	Red blood cell storage medium for extended storage
WO2010039994A2 (fr) *	2008-10-01	2010-04-08	Caridianbct, Inc.	Solution d’additif plaquettaire pour leucoréduction des leucocytes dans des plaquettes d’aphérèse
US12089589B2 (en)	2009-10-12	2024-09-17	Hemanext Inc.	Irradiation of red blood cells and anaerobic storage
CN102905522A (zh)	2009-10-12	2013-01-30	新健康科学股份有限公司	用于从红细胞中除去氧的氧消耗装置和方法
US11284616B2 (en)	2010-05-05	2022-03-29	Hemanext Inc.	Irradiation of red blood cells and anaerobic storage
US9199016B2 (en)	2009-10-12	2015-12-01	New Health Sciences, Inc.	System for extended storage of red blood cells and methods of use
CA2781866C (fr)	2009-10-12	2019-12-03	New Health Sciences, Inc.	Systeme de sac de stockage de sang et dispositifs d'epuisement avec capacites d'epuisement en dioxyde de carbone et en oxygene
US11864553B2 (en)	2009-10-23	2024-01-09	Fenwal, Inc.	Methods and systems for providing red blood cell products with reduced plasma
CN106135195A (zh)	2010-02-16	2016-11-23	维亚塞尔有限责任公司	含有精氨酸的组合物和用于处理红细胞的方法
WO2011103177A1 (fr)	2010-02-16	2011-08-25	Viacell, Llc	Compositions contenant un nucleoside et methode de traitement des erythrocytes
US9339025B2 (en)	2010-08-25	2016-05-17	New Health Sciences, Inc.	Method for enhancing red blood cell quality and survival during storage
PT2635114T (pt)	2010-11-05	2020-06-16	New Health Sciences Inc	Irradiação de glóbulos vermelhos e armazenamento anaeróbico
US9067004B2 (en)	2011-03-28	2015-06-30	New Health Sciences, Inc.	Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
EP3662750A1 (fr)	2011-04-07	2020-06-10	Fenwal, Inc.	Procédés et systèmes automatisés pour produire des concentrés de plaquettes avec des volumes de plasma résiduel réduits et des milieux de conservation pour de tels concentrés de plaquettes
ES2984863T3 (es)	2011-08-10	2024-10-31	Hemanext Inc	Dispositivo integrado de filtrado de leucocitos, oxígeno y/o agotamiento de CO2, y separación de plasma
DE102011056142A1 (de) *	2011-12-07	2013-06-13	Manfred Rüdinger	Metabolisierbare Salze und deren Verwendung in Diagnostik und Therapie
ES2900298T3 (es)	2013-02-28	2022-03-16	Hemanext Inc	Dispositivo de agotamiento de gas para productos sanguíneos
PT3970731T (pt)	2015-03-10	2026-02-24	Hemanext Inc	Kits descartáveis de redução de oxigénio, dispositivos e métodos de utilização dos mesmos
WO2016172645A1 (fr)	2015-04-23	2016-10-27	New Health Sciences, Inc.	Récipients de stockage de sang anaérobie
CA2985799A1 (fr)	2015-05-18	2016-11-24	New Health Sciences, Inc.	Procedes pour le stockage de sang total et compositions correspondantes
KR20240132129A (ko)	2016-05-27	2024-09-02	헤마넥스트 인코포레이티드	혐기성 혈액 저장 및 병원체 불활성화 방법
CN110447634A (zh) *	2019-06-27	2019-11-15	浙江省疾病预防控制中心	一种猴红细胞保存液及应用
CN114207101B (zh)	2019-07-31	2024-05-31	埃科莱布美国股份有限公司	免用个人防护设备的脱灰剂组合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB108588A (en) *	1916-10-13	1917-08-16	Robert Henry Davis	Improvements in or in connection with Divers' Weights.
US2786014A (en) *	1952-09-10	1957-03-19	James L Tullis	Platelet preservation
US3629071A (en) *	1970-02-10	1971-12-21	Upjohn Co	Storage-stable hemostatic transfusion suspensions of blood platelets, glucose, magnesium chloride and certain prostaglandins
GB2034463B (en) *	1978-11-11	1983-03-30	Ryan W	Plaetelet reference control
US4390619A (en) *	1981-09-28	1983-06-28	James Clifford Haight	Leukocyte or platelet storage using ion-exchange resins
US4489162A (en) *	1981-12-21	1984-12-18	American Hospital Supply Corporation	Fresh blood (unfixed) hematology control
DE3225408A1 (de) *	1982-07-07	1984-01-12	Biotest-Serum-Institut Gmbh, 6000 Frankfurt	Waessrige loesung zum suspendieren und lagern von zellen, insbesondere erythrozyten
FR2542617B2 (fr) *	1982-07-09	1986-06-06	Rgl Transfusion Sanguine Centr	Solution protectrice pour la conservation de cellules fonctionnelles
CA1216518A (fr) *	1982-11-01	1987-01-13	Gail A. Rock	Milieu ne contenant pas de plasma pour la conservation des plaquettes sanguines
CA1244774A (fr) *	1983-11-09	1988-11-15	Thomas Jefferson University	Milieu de conservation des plaquettes sanguines
US4695460A (en) *	1986-03-19	1987-09-22	American Red Cross	Synthetic, plasma-free, transfusible platelet storage medium

1987
- 1987-09-21 US US07/099,012 patent/US4961928A/en not_active Expired - Fee Related
1988
- 1988-09-20 DE DE3886006T patent/DE3886006T2/de not_active Expired - Fee Related
- 1988-09-20 CA CA000577883A patent/CA1326440C/fr not_active Expired - Fee Related
- 1988-09-20 AT AT88115407T patent/ATE97952T1/de not_active IP Right Cessation
- 1988-09-20 EP EP19880115407 patent/EP0313808B1/fr not_active Expired - Lifetime
- 1988-09-21 ZA ZA887066A patent/ZA887066B/xx unknown
- 1988-09-21 WO PCT/US1988/003268 patent/WO1989002274A1/fr not_active Ceased
- 1988-09-21 NZ NZ226280A patent/NZ226280A/en unknown
- 1988-09-21 AU AU25563/88A patent/AU619224B2/en not_active Ceased
- 1988-09-22 IL IL87830A patent/IL87830A0/xx unknown

Also Published As

Publication number	Publication date
EP0313808B1 (fr)	1993-12-01
EP0313808A3 (en)	1990-03-07
IL87830A0 (en)	1989-03-31
US4961928A (en)	1990-10-09
EP0313808A2 (fr)	1989-05-03
NZ226280A (en)	1991-03-26
ZA887066B (en)	1989-10-25
DE3886006T2 (de)	1994-06-09
AU619224B2 (en)	1992-01-23
DE3886006D1 (de)	1994-01-13
WO1989002274A1 (fr)	1989-03-23
AU2556388A (en)	1989-04-17
ATE97952T1 (de)	1993-12-15

Legal Events

Date	Code	Title	Description
1996-07-27	MKLA	Lapsed

Publication	Publication Date	Title
CA1326440C (fr)	1994-01-25	Milieu de conservation synthetique de globules rouges et de plaquettes exempt de plasma
JP2802067B2 (ja)	1998-09-21	血小板を貯蔵するためのグルコースを含まない培地
US4695460A (en)	1987-09-22	Synthetic, plasma-free, transfusible platelet storage medium
US6743575B2 (en)	2004-06-01	Compositions and methods for the preservation of living tissues
FI81721C (fi)	1990-12-10	Foerfarande foer lagring av blodplaettar och syntetiskt lagringsmedium.
KR100395033B1 (ko)	2003-12-31	산소제거를 사용하여 냉장된 적혈구의 유효저장수명을 연장시키는 방법
CA1264442A (fr)	1990-01-16	Solutions d'electrolytes et leur utilisation in vivo
US6060233A (en)	2000-05-09	Methods for the lyophilization of platelets, platelet membranes or erythrocytes
US20040106094A1 (en)	2004-06-03	Red blood cell composition
JPH09500380A (ja)	1997-01-14	組織保存及び無血手術のための溶液、ならびにそれを用いた方法
JP2008529550A (ja)	2008-08-07	赤血球の保存のための組成物及び方法
US11730676B2 (en)	2023-08-22	Blood storage container containing aqueous composition for the storage of red blood cells
AU722855B2 (en)	2000-08-10	Compositions for the preservation of living biological materials and methods of their use
US4304672A (en)	1981-12-08	Stored blood and liquid system pH control method and apparatus
AU725247B2 (en)	2000-10-12	Compositions and methods for the preservation of living tissues
US6361933B1 (en)	2002-03-26	Solutions for the preservation of tissues
US20040229203A1 (en)	2004-11-18	Compositions and methods for the preservation of living tissues
RU2226093C1 (ru)	2004-03-27	Кардиоплегический раствор "инфузол"
Levine et al.	1991	Bicarbonate secretion in vivo by rat distal tubules during alkalosis induced by dietary chloride restriction and alkali loading.
WO2004112631A1 (fr)	2004-12-29	Formulation et procede de reduction de la deterioration des globules rouges du sang lors du stockage, notamment en ce qui concerne la diminution du niveau de 2,3 diphosphoglycerate
AU742402B2 (en)	2002-01-03	Treatment of leukemia
JP5568103B2 (ja)	2014-08-06	赤血球の保存のための組成物及び方法
Goniakowska et al.	1968	Effect of Tricarboxylic Acid Cycle Intermediates and Related Compounds on the Respiratory Rate of Urostyla cristata and Colpoda cucullus